526 related articles for article (PubMed ID: 21126616)
1. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
Abdel-Karim AR; Banerjee S; Brilakis ES
J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of percutaneous coronary intervention of chronic total saphenous vein graft occlusions in the contemporary era.
Garg N; Hakeem A; Gobal F; Uretsky BF
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1025-32. PubMed ID: 24030975
[TBL] [Abstract][Full Text] [Related]
6. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Coronary Intervention of Saphenous Vein Graft.
Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
[TBL] [Abstract][Full Text] [Related]
8. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.
Ashby DT; Dangas G; Aymong EA; Iakovou I; Kuepper F; Mehran R; Stone GW; Leon MB; Moses JW
J Am Coll Cardiol; 2003 Mar; 41(5):749-52. PubMed ID: 12628717
[TBL] [Abstract][Full Text] [Related]
9. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
[TBL] [Abstract][Full Text] [Related]
11. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
[TBL] [Abstract][Full Text] [Related]
12. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
[TBL] [Abstract][Full Text] [Related]
13. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
[TBL] [Abstract][Full Text] [Related]
15. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.
Ge L; Iakovou I; Sangiorgi GM; Chieffo A; Melzi G; Cosgrave J; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Colombo A
J Am Coll Cardiol; 2005 Apr; 45(7):989-94. PubMed ID: 15808752
[TBL] [Abstract][Full Text] [Related]
16. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
17. Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial.
Abizaid A; Weiner B; Bailey SR; Londero H
Catheter Cardiovasc Interv; 2010 Nov; 76(6):781-6. PubMed ID: 20549692
[TBL] [Abstract][Full Text] [Related]
18. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
Kirtane AJ; Heyman ER; Metzger C; Breall JA; Carrozza JP
JACC Cardiovasc Interv; 2008 Apr; 1(2):186-91. PubMed ID: 19463299
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
[TBL] [Abstract][Full Text] [Related]
20. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
Lee MS; Hu PP; Aragon J; Shah A; Bhatia R; Jones N; Penny W; French W; Tobis J; Mahmud E
Catheter Cardiovasc Interv; 2010 Aug; 76(2):272-8. PubMed ID: 20623716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
